Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (34)
Cluster analysis and display of genome-wide expression patterns
1998 • 16,410 citations
The fundamental role of epigenetic events in cancer
2002 • 5,532 citations
Genetic instabilities in human cancers
1998 • 4,165 citations
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
1994 • 3,536 citations
Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors
1992 • 3,344 citations
The IARC TP53 database: New online mutation analysis and recommendations to users
2002 • 1,248 citations
Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer
2000 • 927 citations
Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden
2002 • 896 citations
A Mutator Phenotype in Cancer 1
2001 • 675 citations
Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients
1992 • 563 citations
Detection and Clinical Importance of Micrometastatic Disease
1999 • 505 citations
Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells
1999 • 449 citations
Lack of Effect of Adjuvant Chemotherapy on the Elimination of Single Dormant Tumor Cells in Bone Marrow of High-Risk Breast Cancer Patients
2000 • 387 citations
Prognostic Value of Immunohistochemically Identifiable Tumor Cells in Lymph Nodes of Patients with Completely Resected Esophageal Cancer
1997 • 370 citations
Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.
1987 • 316 citations
Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases
1996 • 314 citations
An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control
1998 • 241 citations
Prognostic significance of bone marrow micrometastases in patients with gastric cancer.
1996 • 195 citations
Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer.
1994 • 183 citations
Genetic divergence in the clonal evolution of breast cancer.
1996 • 164 citations
Precise microdissection of human prostate cancers reveals genotypic heterogeneity.
1998 • 159 citations
Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer.
1995 • 120 citations
Cytogenetic analysis of pancreatic carcinomas: Intratumor heterogeneity and nonrandom pattern of chromosome aberrations
1998 • 116 citations
DISSEMINATED CYTOKERATIN POSITIVE TUMOR CELLS IN THE BONE MARROW OF PATIENTS WITH PROSTATE CANCER: DETECTION AND PROGNOSTIC VALUE
2001 • 100 citations
Adjuvant therapy of colon cancer
2001 • 82 citations
Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases.
1997 • 78 citations
Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients
1998 • 55 citations
Epithelial cells in bone marrow of oesophageal cancer patients: a significant prognostic factor in multivariate analysis
2000 • 54 citations
Cytogenetic polyclonality in tumors of the breast
1997 • 54 citations
Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer
2000 • 47 citations
Adjuvant and neoadjuvant therapy in prostate cancer
2001 • 36 citations
Adjuvant and neoadjuvant treatment of breast cancer
2001 • 29 citations
The biology and analysis of single disseminated tumour cells
2000 • 28 citations
Introduction: The evolution of early systemic therapy
2001 • 1 citations